Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ray Dalio On Why Investors Shouldn’t Fear Potential Rate Hike, And Why Quantitative Easing Is Bound For A Comeback

Hedge fund legend Ray Dalio plays down the importance of a potential interest rate hike by the Federal Reserve in a recent interview with Bloomberg’s Tom Keen and Michael McKee. Instead, Dalio is worried about the effects of the next downturn and how the Fed is going to respond to that, as the impact of quantitative easing is weaker with every stage. He believes the central bank should not increase the interest rates and is convinced that the Fed will eventually return to quantitative easing. The Fed is set to issue its latest decision on interest rates later today, following a two-day policy meeting.


With a public equity portfolio valued at more than $10 billion, Ray Dalio’s Bridgewater Associates is one of the biggest hedge funds in the world. A stock market maestro, Dalio bought his first shares at the age of 12, using the money he made as a caddy. He founded Bridgewater in 1973 following short spells at Dominick & Dominick LLC and Shearson Hayden Stone. In 2011, Dalio stepped down from his position as CEO of Bridgewater and has assumed a “mentor” role as he continues to serve as co-CIO, working together with Robert Prince and Greg Jensen. The biggest chunk of Bridgewater’s funds is locked in equity index funds, although these positions were slightly reduced during the second quarter of 2015. The fund’s equity plays are well spread among a number of sectors, with several technology and energy stocks among the top positions.

Ray Dalio
Ray Dalio
Bridgewater Associates

Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith (and money) in large-cap stocks. In forward tests since August 2012 these top small-cap stocks beat the market by an impressive 60 percentage points, returning 118% (read the details here). Follow the smart money into only their best investment ideas all while avoiding their high fees.

Comparing the current state of the economy with the situation prior to the 2008 recession, Dalio hints that the Fed is wrong to focus their attention only on certain domestic economic indicators and states that they are putting too much emphasis on the short-term debt cycle and not enough on the long-term cycle. With U.S corporate coffers flush with cash, a status reflected by the large number of share buyback programs and M&A activity, and a global environment screaming for lower borrowing costs, Dalio believes a large increase to the interest rate in the near future is highly unlikely.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.